Muscle Degeneration: Types, Causes, Symptoms, and Management

Muscle degeneration encompasses disorders with progressive loss of muscle structure and function. Terms: muscular dystrophy (genetic), myopathy (acquired/genetic muscle disease), sarcopenia (age-related).

Major Categories and Examples

1. Genetic Muscular Dystrophies

  • Duchenne (DMD): X-linked, DMD gene (dystrophin). Onset 3–5 years; wheelchair by teens; cardiomyopathy, respiratory failure. Life expectancy ~30 with modern care.
  • Becker (BMD): Milder, later onset, some functional dystrophin.
  • Myotonic dystrophy type 1 (DM1): DMPK CTG repeat; multisystem (myotonia, cataracts, endocrine, cardiac).
  • Limb-girdle (LGMD): >30 subtypes; proximal weakness; variable severity.
  • Facioscapulohumeral (FSHD): DUX4 dysregulation; face, scapula, humeral weakness.

2. Acquired Myopathies

  • Inflammatory: Dermatomyositis (skin + proximal weakness), polymyositis, inclusion body myositis (IBM — elderly, asymmetric, quadriceps/finger flexors), immune-mediated necrotizing myopathy (IMNM).
  • Endocrine: Thyroid (hyper/hypo), steroid myopathy, vitamin D deficiency.
  • Toxic/Drug-induced: Statins, colchicine, chloroquine, alcohol.
  • Critical illness myopathy: ICU-acquired, sepsis, neuromuscular blockade, corticosteroids → diffuse weakness.

3. Neuromuscular Junction Disorders

  • Myasthenia gravis: Anti-AChR/MuSK antibodies → fatigable weakness (ocular, bulbar, limb).
  • Lambert-Eaton (LEMS): Anti-VGCC; proximal weakness improves with exercise.

4. Age-Related: Sarcopenia

  • Loss of mass, strength, function. Starts ~40s; accelerates >65.
  • Drivers: anabolic resistance, inflammation, denervation, mitochondrial dysfunction, inactivity.
  • Consequences: frailty, falls, fractures, mortality, loss of independence.

Common Symptoms

  • Progressive weakness (proximal > distal typically).
  • Fatigue, exercise intolerance.
  • Muscle atrophy, fasciculations (if neurogenic).
  • Falls, gait difficulty, trouble rising from chair (Gowers' sign in DMD).
  • Dysphagia, respiratory insufficiency (late).

Diagnostic Approach

  1. CK (markedly elevated in dystrophies, IMNM; normal in IBM, MG).
  2. EMG/NCS (myopathic vs. neurogenic).
  3. Muscle MRI (pattern recognition).
  4. Genetic testing (panel, WES/WGS).
  5. Muscle biopsy (if genetic negative or inflammatory suspected).
  6. Autoantibodies (myositis panel, AChR, MuSK).

Management Principles

  • Genetic: Corticosteroids (deflazacort, prednisone) for DMD; exon-skipping (eteplirsen), gene therapy (delandistrogene moxeparvovec). Multidisciplinary clinics.
  • Inflammatory: Immunosuppression (steroids, IVIG, rituximab, mycophenolate).
  • MG: Pyridostigmine, thymectomy, immunosuppression, complement inhibitors (eculizumab, ravulizumab).
  • Sarcopenia: Resistance training (mandatory), protein 1.2–1.5 g/kg, vitamin D, treat comorbidities.
  • Supportive: PT/OT, orthotics, respiratory support, cardiac monitoring, nutrition, psychosocial.

Early specialist referral (neuromuscular neurologist) improves outcomes.

Muscle Strains - Related Articles